Story

百亿美元交易的背后:商业化生产权益正在成为中国生物药对外授权交易的新价值密码

(English) Can New Entrants Win the Biosimilar Race? What Europe's Biosimilar Market Reveals About the Next Competitive Frontier

categoryidArraymk-test